Activity of HspE7, a novel immunotherapy, in patients with anogenital warts

Diseases of the Colon and Rectum

Volumn 45, Issue 4, 2002, Pages 502-507

  Goldstone, Stephen E ^a   Palefsky, Joel M ^b   Winnett, Mark T ^c   Neefe, John R ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Stressgen Biotechnologies   (United States)

Author keywords

Anal cancer; Anal disorders; Anogenital warts; Bisexual males; Condyloma; Homosexual; HspE7; Human papillomavirus; Squamous intraepithelial lesion; Squamous cell carcinoma

Indexed keywords

BCG VACCINE; HEAT SHOCK PROTEIN 65; HYBRID PROTEIN; VIRUS ENVELOPE PROTEIN;

ANUS CANCER; ARTICLE; ASTHENIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HOMOSEXUALITY; HUMAN; IMMUNOTHERAPY; INJECTION PAIN; MALE; RANDOMIZED CONTROLLED TRIAL; WART VIRUS;

EID: 0036114412     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-6229-6     Document Type: Article

References (18)

1. Case definitions for infectious conditions under public health surveillance
2. Epidemiology of genital human papillomavirus infection
3. Genital human papillomaviruses
4. Natural history of cervicovaginal papillomavirus infection in young women
5. Genital warts and their treatment
6. 1998 Guidelines for treatment of sexually transmitted diseases
7. Therapeutic approaches to genital warts
8. The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts
9. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts
10. Phase IIa safety and immunogenicity of a therapeutic vaccine, TA-GW, in persons with genital warts
11. Immune responses to stress proteins: Applications to infectious disease and cancer
12. Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guerin (BCG) hsp65 and HPV16 E7
13. Immunotherapy of a human papillomavirus type 16 E7-expressing tumor by administration of fusion protein comprised of Mycobacterium bovis BCG Hsp65 and HPV16 E7
14. High prevalence of anal squamous intraepithelial lesions and squamous-cell carcinoma in men who have sex with men as seen in a surgical practice
15. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men
16. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men
17. Association of anal dysplasia and human papillomavirus with immunosuppression and HIV infection among homosexual men